Kensey Nash said it received FDA clearance for Meso BioMatrix, a porcine-based mesothelium extracellular matrix used to strengthen weak soft tissues, for example in hernia repair, reconstructive surgery and other forms of general surgery. The company is considering developing partnerships for the product in several markets, including urogynecology and wound care.

Related Summaries